Delving into the Latest Updates on Jilin Huakang Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Urogenital Diseases

Cardiovascular Diseases

Nervous System Diseases

Herbal medicine

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Nervous System Diseases	2
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	2
Herbal medicine	2

Top 5 Target	Count

VDCCs(Voltage-gated calcium channel)	1

评价局部注射复方硫酸铝注射液对比TURBT术治疗非肌层浸润性膀胱癌(Ta/T1期)或良性膀胱肿瘤的安全性和有效性。这是一个多中心、随机、开放、平行、非劣效的试验设计。主要关注TURBT手术和复方硫酸铝注射在第三年的复发率的比较。

[Translation]

To evaluate the safety and efficacy of local injection of aluminum sulfate compound injection compared with TURBT for the treatment of non-muscle invasive bladder cancer (Ta/T1 stage) or benign bladder tumors. This is a multicenter, randomized, open, parallel, non-inferiority trial design. The main focus is on the comparison of the recurrence rate between TURBT surgery and aluminum sulfate compound injection in the third year.

Start Date13 Dec 2017

Sponsor / Collaborator

Chinese People's Liberation Army General Hospital

[+1]

CTR20160209 / RecruitingPhase 3

银花泌炎灵片治疗Ⅲ型前列腺炎（湿热下注证）的随机、双盲、阳性药及安慰剂平行对照、多中心临床试验

[Translation] A randomized, double-blind, positive drug and placebo-controlled, multicenter clinical trial of Yinhua Miyanling Tablets in the treatment of type III prostatitis (damp-heat syndrome)

以阳性药及安慰剂为对照，进一步评价银花泌炎灵片治疗Ⅲ型前列腺炎（湿热下注证）的有效性与安全性，为产品的注册申请提供依据。

[Translation]

Using the positive drug and placebo as controls, the efficacy and safety of Yinhua Miyanling Tablets in the treatment of type III prostatitis (syndrome of damp-heat invasion) were further evaluated to provide a basis for the product registration application.

Start Date24 Aug 2016

Sponsor / Collaborator

Jilin Huakang Pharmaceutical Co. Ltd.

100 Clinical Results associated with Jilin Huakang Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Jilin Huakang Pharmaceutical Co. Ltd.

Login to view more data

10

Literatures (Medical) associated with Jilin Huakang Pharmaceutical Co. Ltd.

Zhongguo Xiandai Zhongyao

Determination of baicalin in Qingnao Jiangya tablets by HPLC

Author: Li, Zhenwei ; Wang, Xiuli ; Liu, Chuangui ; Yu, Yongjia

The objective of this study is to establish a HPLC method for the determination of baicalin in Qingnao Jiangya tablets.The HPLC method was used.The sample was analyzed on an Kromasil C₁₈ (4.6 mm × 250 mm, 5 μm) column, using methanol-0.4% phosphoric acid (50:50) as the mobile phase.The flow rate was 0.8 mL/min^-1 and the detection wavelength was 278 nm.Baicalin had the good linearity in the range of 0.1765-2.118 μg (r = 0.9998).The average recovery was 99.38% (RSD = 0.85%).The method was accurate and reproducible, and could be used for the quality control of Qingnao Jiangya tablets.

Zhongguo Xiandai Zhongyao

Determination of tanshinone II and salvianolic acid B in Xueshuan xinmaining tablets by HPLC

Author: Li, Zhenwei ; Liu, Chuangui ; Wang, Fuwen

The HPLC methods for determination of tanshinone II_A and salvianolic acid B in Xueshuan xinmaining tablets were established.C₁₈ column was used with methanol-water-glacial acetic acid (75:24:1) and methanol-acetonitrile 0.5% formic acid (30:9:61) as mobile phases at the detection wavelength of 270 nm and 286 nm, resp.The linear ranges of tanshinone II_A and salvianolic acid B were 3.44-34.40 μg (r = 0.9992) and 0.29-2.94 μg (r = 0.9999).The average recoveries of tanshinone II_A and salvianolic acid B were 98.80% (RSD = 0.72%) and 99.25% (RSD = 0.54%).

Zhongguo Xiandai Zhongyao

Determination of Salvia miltiorrhiza Bge. in Shexiang Xinnaotong tablet by HPLC

Author: Bi, Mingyan ; Fu, Xiaodong ; Wu, Meixian

The objective of this paper is to establish the method for high performance liquid chromatog. determination of danshensu sodium in Shexiangxinnaotong tablet.The condition for high performance liquid chromatog. was Shim-pack C₁₈ column (150 mm × 4.6 mm, 5 μm) with methanol-[water, DMF, glacial acetic acid (93:2:1)] (11.7:88.3) as the mobile phase.The flow rate was 1 mL/min^-1 and the detection wavelength was 283 nm.The results showed that the standard curve was liner in the range of 0.516-2.58 μg and the correlation coefficient was 0.999 6.The average recovery was 98.8% with relative standard deviation 0.73%.It was concluded that the method shows good separating result, accuracy, reproducibility, and can be used for the quality control of Shexiangxinnaotong tablet.

100 Deals associated with Jilin Huakang Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Jilin Huakang Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 2 Clinical

1

Phase 3 Clinical

Approved

2

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Xueshuanxinmaining tablet	Cerebral Infarction More	Approved
Yinhua Miyanling Tablets	Pyelonephritis More	Approved
Compound aluminum sulfate	Bladder Cancer More	Phase 3
Pseudo-Ginsenoside GQ ( VDCCs )	Angina, Stable More	Phase 2